Trade names Foscavir MedlinePlus a601144 ATC code J05AD01 (WHO) CAS ID 63585-09-1 | AHFS/Drugs.com Monograph Routes of
administration Intravenous Molar mass 126.005 g/mol | |
 | ||
Pregnancy
category AU: B3
US: C (Risk not ruled out) | ||
Foscarnet is the conjugate base of the chemical compound with the formula HO2CPO3H2. Foscarnet sodium is used as an antiviral medication.
Contents
Foscarnet was approved for medical use in 1991.
Medical use
This phosphonic acid derivative (marketed by Clinigen as foscarnet sodium under the trade name Foscavir) is an antiviral medication used to treat herpes viruses, including drug-resistant cytomegalovirus (CMV) and herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2). It is particularly used to treat CMV retinitis. Foscarnet can be used to treat highly treatment-experienced patients with HIV as part of salvage therapy.
Mechanism of action
Foscarnet is a structural mimic of the anion pyrophosphate that selectively inhibits the pyrophosphate binding site on viral DNA polymerases at concentrations that do not affect human DNA polymerases.
In individuals treated with the DNA polymerase inhibitors acyclovir or ganciclovir, HSV or CMV particles can develop mutant protein kinases (thymidine kinase or UL97 protein kinase, respectively) that make them resistant to these antiviral drugs. However, unlike acyclovir and ganciclovir, foscarnet is not activated by viral protein kinases, making it useful in acyclovir- or ganciclovir-resistant HSV and CMV infections.
However, acyclovir- or ganciclovir-resistant mutants with alterations in viral DNA polymerase may also be resistant to foscarnet.
Administration
Intravenous infusion or intravitreous injection.